RT Journal Article
SR Electronic
T1 Intratumoral administration of the immunologic adjuvant AS01<sub>B</sub> in combination with autologous CD1c (BDCA-1)<sup>+</sup>/CD141 (BDCA-3)<sup>+</sup> myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008148
DO 10.1136/jitc-2023-008148
VO 12
IS 1
A1 Tijtgat, Jens
A1 Geeraerts, Xenia
A1 Boisson, Anais
A1 Stevens, Latoya
A1 Vounckx, Manon
A1 Dirven, Iris
A1 Schwarze, Julia Katharina
A1 Raeymaeckers, Steven
A1 Forsyth, Ramses
A1 Van Riet, Ivan
A1 Tuyaerts, Sandra
A1 Willard-Gallo, Karen
A1 Neyns, Bart
YR 2024
UL http://jitc.bmj.com/content/12/1/e008148.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.